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Objectives: This study tested the hypothesis that edema during hypothermic
cardioplegia is caused by the hypotonicity of the perfusate at cold temper-
atures. Methods: The volume of isolated human and rabbit atrial myocytes
was measured by video microscopy under nonischemic conditions. Each cell
served as its own control. Results: After equilibration in 37° C physiologic
buffer (Tyrode’s solution), exposure to 9° C St. Thomas’ Hospital solution
for 20 minutes caused human atrial cells to swell by 20% and rabbit atrial
cells to swell by 10%. Cell volume fully recovered on rewarming in 37° C
physiologic solution. Cell swelling was due to the composition of St.
Thomas’ Hospital solution rather than hypothermia alone. Exposure to
9° C physiologic solution did not significantly affect cell volume. Swelling of
myocytes was largely prevented by replacing most of the Cl– in St. Thomas’
Hospital solution with an impermeant anion so that the product of the
concentrations of K1 and Cl– were the same as in the physiologic solution.
Conclusions: This study suggests that cell swelling during hypothermic
cardioplegia is caused in part by the composition of the cardioplegic
solution. The volume of cardiac myocytes appears to follow a Donnan
equilibrium in the cold, and the perfusate KCl product determines water
movement. Thus, the tonicity of hyperkalemic cardioplegic solutions can be
adjusted to a physiologic value by replacing most Cl– by an impermeant
anion. Following this simple principle, a reformulation of cardioplegic
solutions may be able to minimize iatrogenic myocardial edema. (J Thorac
Cardiovasc Surg 1998;115:1189-95)
Hypothermic hyperkalemic cardioplegia is thecornerstone of most strategies for arresting and
protecting the myocardium during operative inter-
vention.1 However, cardioplegic arrest can lead to
significant postoperative abnormalities. Metabolic
intermediates and mitochondrial respiration are dis-
turbed,2-4 left ventricular function is depressed,2, 5-8
and rhythm and conduction abnormalities are prev-
alent.9, 10 Myocardial water content increases4-8, 11
and cellular swelling is observed with both crystal-
loid and blood cardioplegia.12, 13 Cellular edema is
thought to contribute to the observed mechanical
dysfunction,6-8 slowed conduction and arrhythmo-
genesis,10 and decreased coronary flow on reperfu-
sion.8, 14, 15
It has long been assumed that the cellular edema
associated with cardioplegia is induced by ischemia
or inhibition of the Na1-K1 pump by hypothermia.1
An additional mechanism may be a direct conse-
quence of the composition of the isosmotic car-
dioplegic solution. A solution may be isosmotic with
plasma but still induce myocardial cell swelling if it
is hypotonic. Osmolarity is a property of the solution
alone, whereas tonicity depends on properties of
both the solution and membrane and can be depen-
dent on temperature.16 Previously, we demonstrated
that cold St. Thomas’ Hospital solution is hypotonic
for rabbit ventricular myocytes and induces cell
swelling in the absence of ischemic injury.17 The
situation for human myocytes remains unclear, how-
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ever, because cell volume regulation is species-
dependent.16, 18 Our experiments were designed to
determine whether hypothermic St. Thomas’ Hospi-
tal cardioplegic solution caused human atrial myo-
cytes to swell in the absence of ischemic injury.
Parallel studies were conducted on rabbit atrial
myocytes.
Materials and methods
Isolation of myocytes. Both human and rabbit atrial
myocytes were studied. Rabbits (New Zealand White, 1.5
to 3.0 kg, either sex) were humanely put to death with
anesthesia (acepromazine maleate [INN: acepromazine],
25 mg/kg; rompum, 5 mg/kg; ketamine, 50 mg/kg), and the
right atria were removed. Human right atrial tissue was
obtained in accordance with a protocol approved by the
Committee on the Conduct of Human Research at the
Medical College of Virginia, Virginia Commonwealth
University, from 14 patients undergoing cardiac opera-
tion. Right atrial tissue was used because of the ease of
availability compared with ventricular tissue. Samples
were taken from the tip of the right atrial appendage
immediately before cannulation to establish extracorpo-
real circulation. All patients were undergoing coronary
artery bypass grafting; the cases represented randomly
selected men and women ranging in age from 44 to 70
years. All cardioactive drugs were stopped 12 hours before
operation. The perioperative drugs given were consistent
among all patient groups and included heparin, 300
IU/mg, vancomycin, 1 gm intravenously, and routine
anesthetic agents. Human tissue samples and isolated
myocytes were considered potentially infectious and were
handled accordingly.
Human and rabbit myocytes were isolated using a
technique modified from methods previously de-
scribed.19-21 The tissue samples, ranging in size from 5 to
10 mm, were placed in a room temperature flask contain-
ing an oxygenated HEPES buffered solution containing
(in millimoles per liter): 120 NaCl, 5.4 KCl, 0.5 MgSO4,
5.0 sodium pyruvate, 20 glucose, 20 taurine, 30 2,3-
butanedione monoxime (BDM), 10 HEPES buffer, and 6
nitrilotriacetic acid (NTA) and was titrated to pH 7.3 with
NaOH. Human tissue was transported to the laboratory
for processing within 10 minutes of excision and was
placed in a Petri dish containing the same Ca21-free
HEPES-buffered solution used for transport but without
NTA. The tissue was rinsed vigorously for 2 minutes and
was sliced into 1 to 3 mm pieces using a sterile No. 10
scalpel blade.
Tissue slices were placed in a 25 ml Erlenmeyer flask in
a 37° C reciprocating shaker bath (model 25; Precision
Scientific, Chicago, Ill.) and were dissociated into isolated
myocytes in HEPES-buffered solution modified by the
addition of enzymes and 50 mmol/L CaCl2 and the omis-
Fig. 1. Relative cell volume of (A) human atrial myocytes (n 5 6) and (B) rabbit atrial myocytes during
20 minutes in 9° C St. Thomas’ Hospital solution (St. T.) and 20 minutes of rewarming in 37° C physiologic
solution (Tyrode’s solution). Cell volume is expressed relative to that under control conditions. Unfilled
symbols represent a statistically significant change from control (p , 0.05). A, Human cells rapidly swelled
on exposure to cold St. Thomas’ Hospital solution. Volume transiently decreased below the control level
on rewarming. B, Rabbit cells rapidly swelled on exposure to cold St. Thomas’ Hospital solution. Volume
transiently decreased on rewarming. Cell swelling in human atrial myocytes (A) was significantly greater
than that in rabbit atrial myocytes (B). P, Physiologic solution.
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sion of NTA. A three-step procedure was used: (1)
protease, type XXIV (Sigma Chemical, St. Louis, Mo.), 4
U/ml for 15 minutes; (2) collagenase A (Boehringer
Mannheim, Indianapolis, Ind.), 1 mg/ml, and hyaluroni-
dase (Sigma), 0.5 mg/ml, for 20 minutes; (3) collagenase
A, 1.5 mg/ml, alone for one or two 20-minute cycles. The
isolate was filtered through a 250 Fm nylon mesh to
remove debris, and myocytes were gently centrifuged and
washed three times in HEPES-buffered solution contain-
ing 30 mmol/L BDM and 250 Fm Ca21. Cells were stored
in this solution at room temperature until used for
imaging.
Imaging. An aliquot of myocytes was placed in a poly-
L-lysine–coated chamber and allowed to settle for 5
minutes. Then the chamber was perfused with 37° C
physiologic buffer solution at a flow rate of 5 ml/min. The
physiologic (modified Tyrode’s) solution contained (in
millimoles per liter): 130 NaCl, 5 KCl, 2.5 CaCl2, 1.75
NaH2PO4, 1.2 MgSO4, and 24 NaHCO3 and was equili-
brated with 95% oxygen and 5% carbon dioxide and
titrated to pH 7.4 with NaOH.
Myocytes were placed in a custom-made well for the
entire perfusion period. Cells were constantly perfused at 4
to 5 ml/min. Cooling and rewarming occurred rapidly over a
30- to 45-second period. The cold and warm solutions were
separately maintained, and perfusion was changed by turn-
ing a three-way stopcock. Viable cells were chosen by several
morphologic criteria, including sharp borders, no vacuoles in
the cytoplasm, clear and distinct striations, and normal rod
shape. If cells showed any evidence of contraction, they were
excluded from the study.
Cell images were displayed on a video monitor (VM-
1220, Hitachi Denshi, Tokyo, Japan) by a high-resolution
CCD camera (HP-101A, Hitachi) mounted on an inverted
microscope (Diavery, Leitz, Wetzlar, Germany) equipped
with Hoffman modulation optics (Modulation Optics,
Greenvale, N.Y.). Hoffman optics were chosen to enhance
contrast without the “halo” that surrounds cells viewed
with phase contrast. The total magnification of the video-
optical system, determined with a stage micrometer, was
31912 with a 340 objective. Usually, only a single myo-
cyte was visible at one time.
Cell volumes were measured by methods developed in
this laboratory.17, 22, 23 Images of the myocytes were cap-
tured using custom software and a video-frame grabber
(Targa 16/32, Truevision, Santa Clara, Calif.) in a Pentium
computer. The resolution of the digitization was 0.2
mm/pixel. The borders of the cell images were traced using
JAVA image analysis software (Jandel Scientific, San
Rafael, Calif.). JAVA provided contrast enhancement,
image magnification, and an edge-tracing function that
identified the borders of the cell with operator assistance.
Relative cell volume was estimated by use of a custom
program written in ASYST (Keithley Asyst, Tauton,
Mass.).
Changes in the width and thickness of isolated myocytes
in test solutions are proportional.22 Therefore, relative
cell volume was determined as:
Volumetest/volumecontrol 5 (Areatest 3 widthtest)/
(Areacontrol 3 widthcontrol)
Fig. 2. Relative cell volume of (A) human atrial myocytes (n 5 4) and (B) rabbit atrial myocytes (n 5 4)
during 20 minutes in 9° C physiologic solution and 20 minutes of rewarming at 37° C in the same solution.
Hypothermia in physiologic solution did not significantly affect either human or rabbit atrial cell volume.
P, Physiologic solution.
The Journal of Thoracic and
Cardiovascular Surgery
Volume 115, Number 5
Shaffer, Baumgarten, Damiano 1 1 9 1
On the basis of repeated measurements of single images
and measurements of multiple images, estimates of cell
volume have been shown to be reproducible to less than
1%.17, 22, 23
Experimental protocol. Cells were perfused for 20 min-
utes in 37° C Tyrode’s solution, a physiologic buffer, to
establish baseline cell volumes. Cells were then perfused
with 9° C Tyrode’s solution or St. Thomas’ Hospital
solution for 20 minutes. The cell was then reperfused for
20 minutes in warm 37° C Tyrode’s solution. Cell volume
was measured every 1 to 5 minutes throughout the entire
study. St. Thomas’ Hospital solution contained (in milli-
moles per liter): 110 NaCl, 10 NaHCO3, 16 KCl, 16
MgCl2, and 1.2 CaCl2. The fact that St. Thomas’ Hospital
solution is hyperkalemic with a near normal Cl– concen-
tration may explain the cause of cellular edema. Under
hypothermic conditions, passive fluxes of ions modulate
cell volume in accord with a Donnan equilibrium.16 In a
Donnan equilibrium system, the membrane potential
(Em) and the Nernst equilibrium potentials for K
1 and
Cl– are equal. Writing this relationship and simplifying
gives:
Em 5 2 (RT/F)ln([K1]i/[K
1]o) 5
2 (RT/F)ln([CI2]o/[CI
2]i)
[K1]o 3 [Cl–]o 5 [K1]I 3 [Cl–]I
where the bracketed chemical symbols refer to intracellu-
lar, I, and extracellular, o, concentrations, R is the gas
constant, T is the temperature (°K), and F is Faraday’s
constant. As a consequence of these relationships, in-
creasing the KCl product of the extracellular solution
leads to an accumulation of K1 and Cl– within the cell,
and water follows osmotically. St. Thomas’ Hospital solu-
tion has a much greater KCl product, 2566.4 mmol/L2,
than either blood plasma (350 to 550 mmol/L2) or the
control physiologic solution used here (700 mmol/L2).
Thus Donnan equilibrium predicts cellular edema will
result on exposure to St. Thomas’ Hospital solution. To
test whether the high KCl product of St. Thomas’ Hospital
solution was responsible for cell swelling, methanesulfo-
nate, a large poorly permeant anion, was substituted for
part of the Cl– in St. Thomas’ Hospital solution. The KCl
product of the modified low Cl– St. Thomas’ Hospital
solution was equal to that of the physiologic buffer.
Statistics. Data are reported as mean 6 standard error,
and all statistical calculations were done with SigmaStat
(Jandel). Analysis of variance used a repeated measures
design. Because the variance tended to vary with the
treatment mean, a logarithmic transform was applied to
the data before analysis; the variance of the transformed
data was more appropriate for the analytical model.
Comparisons of treatment means to a control was done
using Dunnett’s procedure. In cases in which only a single
comparison was used, Student’s t test was used.
Results
Under control conditions, the dimensions of hu-
man atrial cells were: width, 18.1 6 1.3 mm; length,
131.1 6 5.1 mm; volume, 38.9 6 7.3 pl (n 5 14);
Fig. 3. Relative cell volume of (A) human atrial myocytes (n 5 4) and (B) rabbit atrial myocytes (n 5 4)
during 20 minutes in 9° C low Cl– (43.75 mmol/L) St. Thomas’ Hospital solution (St. T.) and 20 minutes of
rewarming in 37° C physiologic solution (Tyrode’s solution). The KCl product of low Cl– St. Thomas’
Hospital solution was the same as that of physiologic solution. Unfilled data symbols represent a significant
change from control (p , 0.05). P, Physiologic solution.
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rabbit atrial cells were: width, 16.6 6 1.3 mm; length,
107.9 6 7.3 mm; volume, 33.0 6 6.8 pl (n 5 14).
These calculations of volume made the assumption
that cells were brick-shaped with equal thickness
and width. If the cross-section was cylindric, the
absolute cell volumes were overestimated by a factor
of 4/p, 1.27. To avoid this uncertainty in the remain-
ing results, cell volumes were expressed relative to
that in control solution.
The effect of St. Thomas’ Hospital solution on
relative cell volume. Human atrial myocytes rapidly
swelled when perfused with St. Thomas’ Hospital
solution (n 5 6) (Fig. 1, A). The swelling reached
statistical significance within 20 seconds, and rela-
tive cell volume increased by 12.1% 6 1.5% and
19.3% 6 0.6% after 5 and 20 minutes, respectively.
Half of the volume increase occurred within the
initial 3.6 6 1.5 minutes in cold St. Thomas’ Hospi-
tal solution. The observed volume changes were a
result of a change in the width of the cell; cell length
stayed the same as in the control solution.
On rewarming in 37° C physiologic buffer, cell
volume rapidly decreased to a value 8.8% 6 1.1%
(p , 0.009) less than the control volume. This
shrinkage was transient. The half-time for recovery
was 7.4 6 2.3 minutes, and after 20 minutes, relative
cell volume was 2.0% 6 1.7% less than control.
Because previous work on the effect of cardiople-
gia on the volume of isolated myocytes was done
using rabbit ventricular cells,22 we also studied rab-
bit atrial myocytes to examine whether the effect of
cardioplegic solutions was tissue-specific (atrial vs
ventricular) or species-specific (human vs rabbit).
Rabbit atrial myocytes also rapidly swelled during
the exposure to 9° C St. Thomas’ Hospital solution
(n 5 6) (Fig. 1, B). The swelling was statistically
significant within 40 seconds of exposure to cold
cardioplegia, and relative cell volume increased by
8.1% 6 0.8% and 9.4% 6 0.8% after 5 and 20
minutes, respectively. The swelling of rabbit atrial
myocytes was only about half that of human atrial
myocytes (p 5 0.0001). In contrast, rabbit atrial cell
swelling was nearly identical to the swelling previ-
ously reported for rabbit ventricular cells in hypo-
thermic St. Thomas’ Hospital solution, 9.2%.17 The
differences in swelling between human and rabbit
atrial cells may reflect a true species difference or
the effects of in vivo disease processes.
When rabbit atrial cells were rewarmed in physi-
ologic solution, relative cell volume decreased rap-
idly and transiently fell below baseline by 8.4% 6
1.1%. The half-time for recovery from shrinkage
was 1.0 6 0.3 minutes, significantly faster than for
human cells (p 5 0.015).
The hypotonicity and resulting cell swelling could
be due to hypothermia itself or to the composition
of St. Thomas’ Hospital solution. To distinguish
between these two possibilities, isolated myocytes
were cooled to 9° C and rewarmed to 37° C in the
same physiologic solution to test the effect of tem-
perature alone. Experiments on both human (Fig. 2,
A) and rabbit (Fig. 2, B) myocytes revealed that cell
volume was not significantly affected during expo-
sure to cold physiologic buffer solution or during
subsequent rewarming.
Prevention of edema in cold St. Thomas’ Hospital
solution. The swelling of both human and rabbit
atrial myocytes was markedly reduced with cold low
Cl– St. Thomas’ Hospital solution. For human atrial
cells the maximum swelling in cold low Cl– St.
Thomas’ Hospital solution was 3.7% 6 1.0% (n 5
4), (Fig. 3, A), only one fifth as much as the 19.3%
swelling in standard St. Thomas’ Hospital solution
(Fig. 1, A). Nevertheless, swelling of human atrial
myocytes remained statistically significant with re-
spect to control after 7 minutes in low Cl– St.
Thomas’ Hospital solution. In contrast, rabbit atrial
cells did not significantly swell during a 20-minute
exposure to low Cl– St. Thomas’ Hospital solution
(Fig. 3, B). On rewarming, both human and rabbit
myocytes that had been exposed to low Cl– St.
Thomas’ Hospital solution transiently shrank to less
than their control volumes (3.5% 6 0.8% and 7.6%
6 2.0%, respectively) (Fig. 3, A). However, after 20
minutes of recovery in warm physiologic solution,
both had returned to their baseline volumes.
Discussion
Physiologic basis for cardioplegia-induced cellu-
lar edema. Although cardioplegia is intended to
protect the myocardium during elective cardiac ar-
rest,1 this study demonstrated that 9° C St. Thomas’
Hospital solution rapidly induced cellular edema in
the absence of ischemia in both human and rabbit
atrial myocytes. The composition of St. Thomas’
Hospital solution was found to be critical to the
development of edema. Cell swelling was absent or
markedly reduced during hypothermia in a low Cl–
(43.75 mmol/L) St. Thomas’ Hospital solution or in
a physiologic solution. The simplest explanation for
these data is that cardiac cells behave as a Donnan
equilibrium system in the cold. This means that
altering the extracellular KCl product will cause a
redistribution of intracellular K1 and Cl–, and water
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will follow affecting cell volume.16 It is unlikely that
myocyte swelling was due to the choice of crystalloid
solution rather than blood as a vehicle for delivery.
Previous work has shown that isolated myocytes
swell in both blood and crystalloid cardioplegic
solutions.13
Although these data strongly suggest that the KCl
product is an important factor, they are not conclu-
sive in this regard. Further studies are necessary to
clarify this issue, including the investigation of car-
dioplegic solutions of various KCl products. This
would help clarify whether the effect of sodium
methanesulfonate is dependent on the Cl– concen-
tration. The effect of sodium methanesulfonate it-
self needs to be examined by studying whether other
impermeant anions have a similar effect.
It has been suggested previously that inhibition of
the Na1-K1 pump by hypothermia might lead to cell
swelling during cardioplegia in the absence of isch-
emia.1, 24 Each cycle of the Na1-K1 pump extrudes
3 Na1 while taking up 2 K1, a net efflux of osmot-
ically active particles. As Na1 passively enters the
cell, pump inhibition allows the accumulation of
Na1 and thus water. However, in this study inhibi-
tion of the Na1-K1 pump by hypothermia was not
sufficient to cause atrial myocyte swelling. Ventric-
ular myocyte volume and cell water also have been
shown to be resistant to Na1-K1 pump inhibi-
tion.25, 26 Failure to swell despite pump inhibition is
consistent with the view that the leak of Na1 into
quiescent cardiac cells is small. On the other hand,
depolarization to near –50 mV, as occurs during
hyperkalemic arrest, increases Na1 influx and ele-
vates the cytoplasmic [Na1].24 This may explain the
more severe swelling of atrial cells in St. Thomas’
Hospital solution and explain why low Cl– St.
Thomas’ Hospital solution failed to fully abolish
their swelling. Alternatively, human atrial cells may
be more permeant to methanesulfonate, the Cl–
replacement, than rabbit myocytes.
Limitations. Studying isolated myocytes has the
great advantage of permitting direct measurement
of cell volume over time in the absence of isch-
emia. However, several factors must be consid-
ered before applying the conclusions drawn here
to clinical situations. Isolated myocytes in flowing
solution do not reflect the effects of the complex
geometry of the arrested heart wherein extracel-
lular volume is limited. Cellular edema during
cardioplegic arrest of intact hearts initially results
from a fluid transfer from the interstitial to the
cellular compartment.27 Later, interstitial edema
can develop as fluid moves in from the vascular
compartment. On reperfusion, washout of the
extracellular spaces creates an osmotic gradient
favoring further cell swelling and, in severe cases,
rupture of the cell membrane.28 Moreover, the
role of vascular, neural, and interstitial elements
was ignored. The high K1 in cardioplegic solu-
tions may directly damage vascular endotheli-
um.29 Also, myocardial cellular edema increases
coronary vascular resistance and can limit or
prevent effective reperfusion.14, 15 Thus, the
present investigation only considered one of the
many factors contributing to cellular edema and
cardiac dysfunction. This study also involved only
a short period of exposure to cardioplegia rather
than the prolonged times commonly used in the
operating room. The length of exposure is limited
by the need to maintain viable myocytes. How-
ever, this model has been well accepted in the
literature for its usefulness in providing insights
into the mechanisms of cardioplegic injury.13, 17
The comparison between normal rabbit atria
and the atria from patients with coronary artery
disease may not be valid because of underlying
pathologic conditions in the human myocytes.
However, because both species reacted to cardio-
plegia in a similar manner, it is unlikely that this
had a major effect on our results. Moreover, none
of these patients had a history of atrial arrhyth-
mias or visible atrial pathology at the time of
operation.
Clinical implications. The detrimental effects of
edema on cardiac function have long been recog-
nized, and previous attempts have been made to
limit edema osmotically with improved cardiopro-
tection as judged by better recovery of function,
blood flow, and metabolic intermediates.6-8, 15 How-
ever, this study emphasizes that the tonicity of the
cardioplegic solution, rather than its osmolarity, is a
more important factor in controlling myocardial
edema during cardioplegia. Isosmotically replacing
Cl– with a poorly permeant anion to lower the KCl
product turned a hypotonic St. Thomas’ Hospital
solution into an isotonic solution and prevented
myocyte swelling in the cold. Cardioplegic solutions
designed in accord with Donnan equilibrium theory
will need to be assessed in intact heart models to
fully evaluate their clinical potential.
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